Tech Company Financing Transactions
EVOQ Therapeutics Funding Round
EVOQ Therapeutics, based in Ann Arbor, raised $2 million from National Institutes of Health.
Transaction Overview
Company Name
Announced On
8/29/2024
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This support will enable us to accelerate the development of our platform, which we believe could offer significant breakthroughs in treating some of the most challenging diseases in autoimmunity.
Company Information
Company Status
Private & Independent
Industry
Infrastructure
Mailing Address
1600 Huron Parkway, Building 520, 2nd Floor
Ann Arbor, MI 48109
USA
Ann Arbor, MI 48109
USA
Phone
Undisclosed
Website
Email Address
Overview
EVOQ Therapeutics is developing immunotherapies focused on improving the lives of individuals fighting autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
William Brinkerhoff
Chief Executive Officer
David Giljohann
Chief Operating Officer
Greg Barrett
Chief Scientific Officer
James Moon
VP - Bus. Development
Weston Daniel
VP - Bus. Development
Anna Schwendeman
Browse more venture capital transactions:
Prev: 8/29/2024: Level venture capital transaction
Next: 8/29/2024: Piramidal venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs